Eli Lilly partnership a "monumental effort" to speed up drug creation, despite Wall Street ignoring major AI shift.
France's Finance ​Ministry said on Monday it had received no formal request for investment approval ‌regarding French biotech ...
Eli Lilly won approval for its tirzepatide under the names Mounjaro for type 2 diabetes and Zepbound for weight loss -- in ...
Attorney General Todd Rokita is intensifying his efforts to lower insulin prices and improve healthcare affordability for ...
Wall St. provides estimates for future stock prices of Eli Lilly from 2026 to 2030 based on projected revenue and net income.
Novo Nordisk ( NVO +1.68%) was once the top player in the weight loss drug market. The company's medicine, Wegovy, ...
The lawsuit alleges insulin can cost Eli Lilly just a few dollars to produce, while some consumers are charged hundreds of ...
Eli Lilly came to the 44 th annual JP Morgan Healthcare Conference bolstered by a strong year. 1 While the looming patent cliff still impacts that company’s upcoming strategy, Lilly found itself in a ...